Summary Information:
Xenon Pharmaceuticals Inc. Common Shares
NASDAQ:XENE


email
admin@troach.net
Our Main Pages
Stocks.TRoach.Net
TRoach.Org
TRoach.Net

NOTE: This page is for evaluation of a JFF Project.
This page is NOT updated on a regular basis.
Information on this page should NOT be used for investment purposes.


Xenon Pharmaceuticals Inc. Common Shares
Exchange: NASDAQ
Symbol: XENE
SEC CIK: 0001582313
Phone: (604) 484-3300
200 - 3650 GILMORE WAY
BURNABY A1 V5G 48W

CEO: Simon Pimstone
Price when page updated: 34.70 Date: 2023-12-02
Company Website:
www.xenon-pharma.com

_Description: Xenon is a clinical stage biopharmaceutical company committed to developing innovative therapeutics to improve the lives of patients with neurological disorders. The Company is advancing a novel product pipeline of neurology therapies to address areas of high unmet medical need, with a focus on epilepsy.

IPO YEAR:
2014
Sector:

Industry:

ADRTSO:

MarketCap:
2270410972.00
Beta:
0.0413425599749906
52 Week High:
36.42
52 Week Low:
13.23
52 Week Change:
1.1859819569743233
Short Interest:

Short Date:

Shares Outstanding:
51589279
Dividend Rate:
0
Dividend Yield:
N/A
ExDividend Date:

Latest EPS:

Latest EPS Date:
3 Nov 2022
Float:
0
return on Equity:
-2.70%
Consensus EPS:

Number Of Estimates:

EPS Surprise Dollar:

Eps Surprise Percent:

EBITDA:
-$568.00
ttmEPS:
0
Revenue:
$12.650B
Gross Profit:

Cash:

Debt:

Institution Percent:
18.90%
Revenue Percent:

Revenue Per Employee:

Insider Percent:
55.73%
Return on Assets:
-1.70%
Return on Capital:

Profit Margin:
-5.70%
Price to Sales:
0.47
Price To Book:
0.21
Short Ratio:
1.53
PE Ratio:
0
Employees:
129
1Y Guesstimate
N/A:N/A:N/A




__The following are links to various summary and news pages for
__Xenon Pharmaceuticals Inc. Common Shares [ XENE ].

__Note: Some Links might not have information for the company.


finance.Yahoo.com money.CNN.com NASDAQ research
WalletInvestor.com WSJ.com MarketBeat.com
finviz.com WallMine.com TheGlobeandMail.com
stock1010.com
NASDAQ - General Info SEC Insider Report Ownership Summary
Dividend History insiderbuyingselling.com
Facebook search Twitter search LinkedIn search
PRnewsWire.Com Google Forecast
tdameritrade.com BarChart.com
SeekingAlpha.com Markets.FT.com stocktwits.com
FinTel.io Ldmicro.com bloomberg.com
MarketWatch.com Reuters.com businessinsider.com
fool.com barrons.com zacks.com
GuruFocus.com Investing.com tipranks.com
thestreet.com nytimes.com earningswhispers.com
marketchameleon.com sunshineavenue.com stockinvest.us
stockanalysis.com stockconsultant.com ycharts.com
financialcontent.com docoh.com foxbusiness.com
cnbc.com investorsobserver.com tradingview.com
investopedia.com tmxmoney.com invest.cnyes.com
ask.com bing.com brave.com
duckduckgo.com ecosia.org excite.com
exalead.com gibiru.com hotbot.com
www.info.com infospace.com lycos.com
lukol.com metacrawler.com mojeek.com
becovi.com searx.thegpm.org search.com
swisscows.com webcrawler.com yahoo.com
yandex.com yep.com you.com




INDEX




Page design by: TRoach
Page Last Updated: 2023-12-02